SPIRE INC - SR 6 3/8 03/01/2086 (SRJN) Fundamental Analysis & Valuation

NYSE:SRJN • US84857L7055

Current stock price

24.88 USD
+0.04 (+0.16%)
Last:

This SRJN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. SRJN Profitability Analysis

1.1 Basic Checks

  • In the past year SRJN was profitable.
  • SRJN had a positive operating cash flow in the past year.
  • In the past 5 years SRJN has always been profitable.
  • Each year in the past 5 years SRJN had a positive operating cash flow.
SRJN Yearly Net Income VS EBIT VS OCF VS FCFSRJN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M

1.2 Ratios

  • SRJN has a worse Return On Assets (2.27%) than 73.33% of its industry peers.
  • With a Return On Equity value of 7.87%, SRJN is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • The Return On Invested Capital of SRJN (4.23%) is worse than 66.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SRJN is below the industry average of 6.19%.
  • The last Return On Invested Capital (4.23%) for SRJN is above the 3 year average (3.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.27%
ROE 7.87%
ROIC 4.23%
ROA(3y)2.12%
ROA(5y)2.23%
ROE(3y)7.27%
ROE(5y)7.75%
ROIC(3y)3.88%
ROIC(5y)3.96%
SRJN Yearly ROA, ROE, ROICSRJN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • SRJN has a Profit Margin (10.52%) which is in line with its industry peers.
  • SRJN's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 21.35%, SRJN is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SRJN has grown nicely.
Industry RankSector Rank
OM 21.35%
PM (TTM) 10.52%
GM N/A
OM growth 3Y4.45%
OM growth 5Y2.03%
PM growth 3Y3.46%
PM growth 5Y21.14%
GM growth 3YN/A
GM growth 5YN/A
SRJN Yearly Profit, Operating, Gross MarginsSRJN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. SRJN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRJN is destroying value.
  • SRJN has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SRJN has more shares outstanding
  • Compared to 1 year ago, SRJN has a worse debt to assets ratio.
SRJN Yearly Shares OutstandingSRJN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
SRJN Yearly Total Debt VS Total AssetsSRJN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.54, we must say that SRJN is in the distress zone and has some risk of bankruptcy.
  • SRJN has a worse Altman-Z score (0.54) than 73.33% of its industry peers.
  • SRJN has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
  • SRJN's Debt to Equity ratio of 1.42 is in line compared to the rest of the industry. SRJN outperforms 46.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACC0.81
WACC5.2%
SRJN Yearly LT Debt VS Equity VS FCFSRJN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • SRJN has a Current Ratio of 0.61. This is a bad value and indicates that SRJN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of SRJN (0.61) is worse than 66.67% of its industry peers.
  • A Quick Ratio of 0.45 indicates that SRJN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.45, SRJN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.45
SRJN Yearly Current Assets VS Current LiabilitesSRJN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SRJN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 19.46% over the past year.
  • SRJN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.46% yearly.
  • Looking at the last year, SRJN shows a small growth in Revenue. The Revenue has grown by 2.55% in the last year.
  • Measured over the past years, SRJN shows a small growth in Revenue. The Revenue has been growing by 5.94% on average per year.
EPS 1Y (TTM)19.46%
EPS 3Y4.64%
EPS 5Y3.46%
EPS Q2Q%32.09%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y4.05%
Revenue growth 5Y5.94%
Sales Q2Q%13.91%

3.2 Future

  • SRJN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.81% yearly.
  • SRJN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.09% yearly.
EPS Next Y18.54%
EPS Next 2Y13.88%
EPS Next 3Y12.73%
EPS Next 5Y9.81%
Revenue Next Year0.84%
Revenue Next 2Y1.57%
Revenue Next 3Y2.97%
Revenue Next 5Y12.09%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SRJN Yearly Revenue VS EstimatesSRJN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
SRJN Yearly EPS VS EstimatesSRJN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. SRJN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 5.07 indicates a rather cheap valuation of SRJN.
  • Based on the Price/Earnings ratio, SRJN is valued cheaper than 100.00% of the companies in the same industry.
  • SRJN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.64.
  • Based on the Price/Forward Earnings ratio of 4.28, the valuation of SRJN can be described as very cheap.
  • SRJN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SRJN is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, SRJN is valued rather cheaply.
Industry RankSector Rank
PE 5.07
Fwd PE 4.28
SRJN Price Earnings VS Forward Price EarningsSRJN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SRJN is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.48
SRJN Per share dataSRJN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • SRJN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SRJN's earnings are expected to grow with 12.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)1.47
EPS Next 2Y13.88%
EPS Next 3Y12.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. SRJN Dividend Analysis

5.1 Amount

  • SRJN has a Yearly Dividend Yield of 3.61%.
  • SRJN's Dividend Yield is comparable with the industry average which is at 3.69.
  • Compared to an average S&P500 Dividend Yield of 1.82, SRJN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

  • The dividend of SRJN has a limited annual growth rate of 4.02%.
  • SRJN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)4.02%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 73.84% of the earnings are spent on dividend by SRJN. This is not a sustainable payout ratio.
  • The dividend of SRJN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP73.84%
EPS Next 2Y13.88%
EPS Next 3Y12.73%
SRJN Yearly Income VS Free CF VS DividendSRJN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M
SRJN Dividend Payout.SRJN Dividend Payout, showing the Payout Ratio.SRJN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SRJN Fundamentals: All Metrics, Ratios and Statistics

SPIRE INC - SR 6 3/8 03/01/2086

NYSE:SRJN (5/1/2026, 7:00:00 PM)

24.88

+0.04 (+0.16%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryGas Utilities
Industry Strength59.01
Industry Growth43.48
Earnings (Last)02-03
Earnings (Next)05-06
Inst Owners92.11%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap1.47B
Revenue(TTM)2.57B
Net Income(TTM)270.30M
Analysts83.75
Price Target27 (8.52%)
Short Float %0.05%
Short Ratio0.97
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly Dividend3.38
Dividend Growth(5Y)4.02%
DP73.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.19%
Min EPS beat(2)-7.62%
Max EPS beat(2)3.24%
EPS beat(4)2
Avg EPS beat(4)25.22%
Min EPS beat(4)-7.62%
Max EPS beat(4)110.14%
EPS beat(8)3
Avg EPS beat(8)12.44%
EPS beat(12)5
Avg EPS beat(12)-2719.4%
EPS beat(16)8
Avg EPS beat(16)-2039.93%
Revenue beat(2)1
Avg Revenue beat(2)-10.32%
Min Revenue beat(2)-23.15%
Max Revenue beat(2)2.52%
Revenue beat(4)2
Avg Revenue beat(4)-9.38%
Min Revenue beat(4)-23.15%
Max Revenue beat(4)2.52%
Revenue beat(8)3
Avg Revenue beat(8)-9.64%
Revenue beat(12)5
Avg Revenue beat(12)-5.43%
Revenue beat(16)9
Avg Revenue beat(16)1.46%
PT rev (1m)0.07%
PT rev (3m)N/A
EPS NQ rev (1m)-0.7%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.02%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.6%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.18%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.07
Fwd PE 4.28
P/S 0.57
P/FCF N/A
P/OCF 2.54
P/B 0.43
P/tB 0.65
EV/EBITDA 7.48
EPS(TTM)4.91
EY19.73%
EPS(NY)5.81
Fwd EY23.35%
FCF(TTM)-4.85
FCFYN/A
OCF(TTM)9.78
OCFY39.3%
SpS43.48
BVpS58.08
TBVpS38.26
PEG (NY)0.27
PEG (5Y)1.47
Graham Number80.1044 (221.96%)
Profitability
Industry RankSector Rank
ROA 2.27%
ROE 7.87%
ROCE 5.4%
ROIC 4.23%
ROICexc 4.23%
ROICexgc 4.75%
OM 21.35%
PM (TTM) 10.52%
GM N/A
FCFM N/A
ROA(3y)2.12%
ROA(5y)2.23%
ROE(3y)7.27%
ROE(5y)7.75%
ROIC(3y)3.88%
ROIC(5y)3.96%
ROICexc(3y)3.89%
ROICexc(5y)3.96%
ROICexgc(3y)4.4%
ROICexgc(5y)4.53%
ROCE(3y)5.34%
ROCE(5y)5.42%
ROICexgc growth 3Y2.04%
ROICexgc growth 5Y0.17%
ROICexc growth 3Y2.84%
ROICexc growth 5Y1.2%
OM growth 3Y4.45%
OM growth 5Y2.03%
PM growth 3Y3.46%
PM growth 5Y21.14%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 5.68
Cap/Depr 281.35%
Cap/Sales 33.65%
Interest Coverage 2.65
Cash Conversion 67.52%
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.45
Altman-Z 0.54
F-Score6
WACC5.2%
ROIC/WACC0.81
Cap/Depr(3y)292.9%
Cap/Depr(5y)280.92%
Cap/Sales(3y)31.77%
Cap/Sales(5y)29.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.46%
EPS 3Y4.64%
EPS 5Y3.46%
EPS Q2Q%32.09%
EPS Next Y18.54%
EPS Next 2Y13.88%
EPS Next 3Y12.73%
EPS Next 5Y9.81%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y4.05%
Revenue growth 5Y5.94%
Sales Q2Q%13.91%
Revenue Next Year0.84%
Revenue Next 2Y1.57%
Revenue Next 3Y2.97%
Revenue Next 5Y12.09%
EBIT growth 1Y10.18%
EBIT growth 3Y8.67%
EBIT growth 5Y8.09%
EBIT Next Year78.85%
EBIT Next 3Y27.27%
EBIT Next 5Y22.28%
FCF growth 1Y-438.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.14%
OCF growth 3Y119.04%
OCF growth 5Y4.23%

SPIRE INC - SR 6 3/8 03/01/2086 / SRJN Fundamental Analysis FAQ

What is the fundamental rating for SRJN stock?

ChartMill assigns a fundamental rating of 4 / 10 to SRJN.


Can you provide the valuation status for SPIRE INC - SR 6 3/8 03/01/2086?

ChartMill assigns a valuation rating of 7 / 10 to SPIRE INC - SR 6 3/8 03/01/2086 (SRJN). This can be considered as Undervalued.


Can you provide the profitability details for SPIRE INC - SR 6 3/8 03/01/2086?

SPIRE INC - SR 6 3/8 03/01/2086 (SRJN) has a profitability rating of 4 / 10.


What is the valuation of SPIRE INC - SR 6 3/8 03/01/2086 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SPIRE INC - SR 6 3/8 03/01/2086 (SRJN) is 5.07 and the Price/Book (PB) ratio is 0.43.


Can you provide the expected EPS growth for SRJN stock?

The Earnings per Share (EPS) of SPIRE INC - SR 6 3/8 03/01/2086 (SRJN) is expected to grow by 18.54% in the next year.